EP2061345A2

EP2061345A2 - Novel preparation of phosphodiesterase of plant origin

Info

Publication number: EP2061345A2
Application number: EP07823801A
Authority: EP
Inventors: Eric Oriol; Nadia Kaid
Original assignee: Lesaffre et Cie SA
Current assignee: Lesaffre et Cie SA
Priority date: 2006-09-12
Filing date: 2007-09-11
Publication date: 2009-05-27
Also published as: AU2007296027A1; WO2008031982A2; FR2905562A1; FR2905562B1; CN101557724A; EA200900433A1; US20090324778A1; CA2661192A1; JP2010502236A; WO2008031982A3

Abstract

The present invention relates to the preparation of a 5'-phospho-diesterase extracted from sorghum, and to the use thereof for the preparation of a composition rich in 5'-nucleotides, in particular of a yeast extract.

Description

NEW PREPARATION OF ORIGINAL PHOSPHODIESTERASE

VEGETABLE

The present invention relates to a process for the preparation of a flavoring agent by enzymatic treatment of yeast, the flavoring agent obtained and its uses.

Yeast extracts are commercially available in the form of powder and paste, and are widely used in the food industry as a flavoring agent. Yeast extracts are defined as concentrates of the soluble fraction of yeasts generally obtained by autolysis or hydrolysis.

Autolysis is essentially a process aimed at damaging the plasma membrane of yeast by activating the proper yeast degradation enzymes (proteases) and resulting in solubilization of intracellular compounds. The yeast extracts can also be obtained by hydrolysis using exogenous reagents or enzymes which allow the release of the intracellular content in a highly degraded form.

Yeast extracts have been widely accepted in the food industry under the name of natural flavoring agents. They are also very competitive financially, compared to other flavoring agents (which are often unnatural), with equivalent aromatic intensity.

These enzymatic yeast treatments are well known in the state of the art. Yeast autolysates, prepared by subjecting yeast to degradation by its own endogenous enzyme material, are well known as food additives.

Autolysis can be triggered by incubating yeast cells at high temperature, adding organic solvents, using increasing NaCl concentration, or combining these different methods.

During autolysis, the main conversion taking place is the degradation of proteins into peptides and amino acids. The resulting autolysates therefore have a bitter flavor and a pronounced typical yeast note. Another disadvantage is that the autolysates mainly contain only 3'-ribonucleotides, which have no contribution in terms of flavor, since the endogenous ribonucleases convert intracellular PARN to 3'-ribonucleotides.

In patent EP 0 354 610 B1 of Quest International BV, there is taught a process for preparing a yeast extract in which, first of all, the wall is degraded with exogenous proteolytic enzymes under anaerobic conditions, and then the RNA is degraded with exogenous enzymes under oxidative conditions. This method makes it possible to obtain an autolysate rich in 5'-nucleodides.

Known taste compounds contained in yeast autolysates include amino acids, peptides, nucleic acids such as 5'-nucleotides, saccharides and organic acids. The 5'-nucleotide content is of considerable importance for flavor and flavor. Such nucleic acids are used as crude compounds in the flavoring of food preparations, for example 5'-inosine mono-phosphate (5'-IMP) or 5'-guanosine mono-phosphate (5'-GMP), but also find applications in the development of pharmaceuticals. The unami flavor is considered the fifth basic flavor as well as the sweet, salty, bitter and sour flavors. The 5'-nucleotides with high flavor enhancer are also generators of the unami flavor, and thus enhance the effect of mono sodium glutamate (MSG), naturally present in yeast extracts. Obtaining 5'-nucleotides requires the hydrolysis of the crude RNA by means of a very specific enzyme, 5'-phosphodiesterase (5'-PDE). Cohn and Volkin (1953) were the first to demonstrate the presence of 5'-phosphodiesterase activity in snake venom. Despite its high efficiency, it can not be used in the agri-food industry for obvious reasons. Other important sources of 5'-PDE include certain fungi such as Penicillium citrinum and some Actinomyces such as Streptomyces aureus. Moreover, 5'-PDE from Penicillium citrinum is commercially available from Amano Enzyme among others, under the name Nucléase RP-IG (or EC3.1.30.1). Because of its very high cost, this enzyme is mainly used on an industrial scale in an immobilized form. Its use in a process for producing yeast extracts enriched with 5'-nucleotides induces very large additional enzymatic costs.

The presence of 5'-PDE activity in certain plant germs has been demonstrated by Schuster (1957). Numerous subsequent studies have been the subject of patent applications and mainly describe methods for producing 5'-nucleotide-rich yeast extracts from extracts of malt rootlets (the malt being germinated barley). . Malt is a by-product of the brewing industry, and therefore can be a cheap source of enzyme for the production of 5'-nucleotides from yeast RNA. In this case, 5'-PDE is prepared by simple decoction of a malt root powder in an aqueous solution containing zinc acetate to stabilize the enzyme, and its use induces a small additional cost for the manufacture of yeast extract enriched in 5'-nucleotides product.

Processes for obtaining yeast derivatives rich in 5'-nucleotides using barley malt as a source of enzymes are for example described in US-A-4,810,509, EP-A-0299078, FR 75 08446 as well as in the reference work "Yeast Technology" by G. Reed and TW Nagodawithana, 2nd edition (Van Nostrand Reinhold, ISBN 0-442 - 31892-8), pages 382 to 385.

The major disadvantage of using 5'-PDE from germinated malt or barley is that it has an allergenic character. In fact, the raw material from which the enzyme, in this case barley, originates, contains hordein, a prolamine close to wheat gliadin, which is allergenic and causes intolerance (celiac disease). In addition, barley is listed in EC Directive 2000/13 / EC, amended by EC Directive 2003/89 / EC as a cereal containing gluten. Thus according to this directive, known as the "allergenic" directive, products containing barley or its derivatives are subject to labeling. The main characteristic of these proteins is that they are not degraded by the acid environment of the stomach, nor by the intestinal digestive enzymes. Remained intact, these proteins are absorbed as such by the intestine and can trigger an immune response. In the case of celiac disease, it is the consumption of these prolamins that causes a reaction of the body. All these prolamins proteins are toxic to so-called celiacs, because their consumption causes a strong inflammatory reaction that damages the surface of the cells of the small intestine. This has the effect of reducing their ability to absorb nutrients such as proteins, fats, carbohydrates, vitamins and minerals. Allergy is associated with symptoms of gastrointestinal nature: abdominal cramps, bloating and chronic diarrhea. From these can arise the malabsorption of several nutrients (iron, calcium, folic acid), malnutrition (anemia and weight loss), fatigue, bone pain, muscle cramps and irritability. Purification of barley malt PDE may be an alternative if the enzyme can be separated from barley prolamine. However, the work published by Ai-Yu Wang et al. ((1993) Biochemistry and Molecular Biology International, pp 1095-1102, Vol 29, No. 6), or by Beluhan et al. ((2003) in Biotechnology Letters 25, pp. 1099-1103) focused on characterizing purified barley malt 5'-PDE without measuring the presence of barley prolamine in their preparations. This purification alternative appears expensive and does not exonerate from an analytical record demonstrating the elimination of gluten from the enzyme preparation but above all from a clinical record proving the absence of allergenicity of the product resulting from the action of this enzyme. . A second alternative is to use a 5'-PDE of microbial origin obtained from strains of filamentous fungi such as Penicillium citrinum or Aspergillus niger, or bacteria such as Actinomyces or Streptomyces. However, these are long developments that go through phases of improvement of strains. In addition, this type of production requires industrial fermentation / purification plants and a process which ultimately results in an expensive enzyme. A third alternative would be to clone a plant 5'-PDE in an industrial microorganism. This alternative has been evaluated by the teams of researchers of the Applicant, but, besides the fact that the sequences coding for this enzyme are not known, this would lead to an enzyme derived from a genetically modified organism (GMO), product type. still very badly perceived by the different customers users.

So the problem so far unresolved, is it to find a source of food enzyme without gluten and which does not present an economic disadvantage as is the case of commercial enzymes currently available on the market. This preparation must, on the other hand, be free of nucleases or phosphatases which degrade RNA fragments or nucleotides, and lead to products of degradation without being able to enhance flavor. It must also not generate tastes or aromatic notes that could be perceived in a troublesome way to the tasting. The Applicant has now discovered, in a particularly unexpected and surprising manner, that sorghum malt could perfectly replace allergenic barley malt in the preparation of yeast extracts rich in 5 'nucleotides. Moreover, sorghum is not included in the list of gluten cereals according to Directive C2003 / 89 / EC, and therefore does not have any allergenic characteristics such as gluten.

The applicant has developed an enzyme preparation of 5'-PDE from a mixture containing seeds and rootlets of sorghum malt.

More particularly, sorghum 5'-phosphodiesterase is obtained by means of a decoction of malted sorghum rootlets. Thus, a powder of sorghum radicles with a particle size of between 20 and 2000 μm, preferably between 100 and 200 μm, is suspended in an aqueous solution of zinc acetate or an equivalent agent, it is to say an agent having the same stabilizing effect of 5'-PDE. The suspension is incubated at a temperature of between 50 and 80 ^° C. for 30 minutes to 4 hours. Preferably, this decoction is carried out with stirring. For example, the powder of rootlets can be used in a proportion of 5 to 20% w / w), preferably 10 to 15%, and in particular 13%. The concentration of zinc acetate is preferably between 0.2 and 5 g / l. In one embodiment alternatively, an integral malt of sorghum containing rootlets is used. Then, in a preferred embodiment, the solubility portion of the solution is recovered. For example, the preparation can be separated on a centrifugal decanter, and then the supernatant is clarified in a centrifugal clarifier. The 5'-PDE sorghum preparation thus obtained can be used for the preparation of a composition rich in 5'-nucleotides, a yeast extract rich in 5 'nucleotides, devoid of gluten.

The present invention thus relates to a method for preparing a 5'-PDE of sorghum comprising the preparation of a decoction of malted sorghum rootlets in an aqueous solution of zinc acetate (0.2 to 5 g / l) to a temperature of between 50 and 80 ^° C. for 30 minutes to 4 hours, and then the elimination of the insoluble fraction. It may also include a concentration step.

The present invention relates to the preparation of 5'-PDE sorghum obtainable by this method and its use for digesting RNA, more particularly for the preparation of a composition rich in 5'-nucleotides, preferably a yeast extract, said composition being free of gluten. It also relates to the use of 5'-PDE extracted from sorghum malt to enrich in 5'-nucleotides a composition containing RNA. It therefore relates to a method for preparing a gluten-free 5'-nucleotide-rich composition, preferably a yeast extract, comprising the treatment of microbial cells so as to release the RNA in the extracellular medium, and the treatment of the suspension obtained by a 5'-PDE sorghum preparation to convert the released RNA to 5'-nucleotides. Examples of other microorganisms that can be used in this process are, for example, a filamentous fungus of the Aspergillus or Trichoderma type or a bacterium, preferably a lactic bacterium of the genus Lactobacillus. The method may comprise an intermediate step of total or partial purification of the RNA (see JP 51106791).

In a preferred embodiment, it comprises treating a yeast extract or a yeast suspension with a 5'-PDE sorghum preparation. The present invention thus relates more particularly to a method for preparing a 5'-nucleotide rich and gluten-free yeast extract, comprising: heating a yeast suspension; treating the yeast suspension with a 5'-phosphodiesterase; separating the insoluble materials from the suspension; and recovering the yeast extract; characterized in that the 5'-phosphodiesterase is extracted from sorghum, in particular malted sorghum, more particularly malted sorghum rootlets.

The yeast useful in the present invention is an edible yeast. According to the invention, the yeast used to prepare the extract preferably belongs to the genus Saccharomyces and more preferably belongs to the species Saccharomyces cerevisiae, including that called Saccharomyces carlsbergensis. Said cells of Saccharomyces cerevisiae yeast are also often called Saccharomyces carlsbergensis when it comes to yeast, the exact taxonomic name being Saccharomyces cerevisiae according to "The Yeasts, a taxonomic study", ^3rd edition, published by NJW Kreger van Rij - 1984 (by cons according to the ^4th edition of this book in 1998, Saccharomyces carlsbergensis has two synonyms Saccharomyces cerevisiae and Saccharomyces pastorianus is the ^3rd edition of this work dating from 1984, which is taken as reference herein) . On the other hand, the yeast may also come from the genus Candida (for example, C. utilis), Pichia, Hansenula, Kluyveromyces (for example K. lactis, K. marxanius or K. fragilis), Torula, Fusarium, Zymonomas and the like. The yeast can come from a culture of fresh yeasts or yeasts that have been used in brewing processes. In a preferred embodiment, the yeast is of the genus Saccharomyces, of the genus Candida or of the genus Kluyveromyces.

The yeast will be chosen so that it has a high RNA content. In a particular embodiment, the RNA content is between 6 and 15% by dry weight.

The yeast may have undergone a pretreatment to increase its RNA content. Such treatments are described in US 3,909,352 and JP 11-196856 by mutation and yeast selection and in JP 5-176757 by limiting potassium sulfate in the culture medium.

The RNA content of the yeast suspension can be increased by adding RNA from a micro-organism authorized for human or animal nutrition. of the Examples of such microorganisms are, for example, a filamentous fungus of the Aspergillus or Trichoderma type or a bacterium, preferably a lactic bacterium of the genus Lactobacillus. In this case, the microorganism is processed to release its RNA content. In a particular embodiment, the RNA can be totally or partially purified by known methods (ultrafiltration, chromatography, or precipitation).

Processes for preparing a yeast extract are well known to those skilled in the art. Such methods are described, for example, in the following patents: EP 249,435; EP 299,078; EP 354,610; EP 466,922; EP 1 199 353; EP 1 479 299; US 3,961,080; US 4,303,680; US 4,810,509. These processes generally comprise a step of heating a yeast suspension, optionally a step of autolysis and / or hydrolysis of the yeast, and preferably a step of separating the insoluble materials from the suspension. . The yeast suspension is a suspension of live yeasts. Preferably, the yeast suspension is plasmolyzed so as to inactivate yeast enzymes, including phosphatases and nucleases, to permeabilize the yeast to release its cellular content and RNA, and preferably to selectively solubilize the yeast. RNA in the extracellular medium, which ultimately allows to obtain 5'-nucleotide titers higher than the RNA content of the yeast suspension. Preferably, the yeast suspension comprises between 10 and 25% of dry matter. In a preferred embodiment, the yeast suspension is heated for 5 minutes to 3 hours at a temperature of from 5 to 95 ° C. In particular, the suspension can be heated for 2 h at 75 ° C. and then cooled to 60 ^° C.

Other techniques well known to those skilled in the art can also be used to release the cellular content of the yeast, for example by mechanical treatment (French press, glass beads, pulsed electromagnetic field, etc.), by treatment. chemical (acids, bases, salts, solvents, detergents, etc.) or by enzymatic treatment (β-glucanases, chitinases, proteases, ...).

Furthermore, the method may also comprise an enzymatic digestion step, the enzymes being selectable from proteases, β-glucanases, amylases, lipases, etc. Thus, the present invention relates to a method for preparing a yeast extract rich in 5'-nucleotide, comprising: a) heating a yeast suspension; b) autolysis and / or enzymatic hydrolysis of the yeast; c) separating the insoluble materials from the suspension; and d) recovering the yeast extract; characterized in that the method comprises treating the yeast suspension with a 5'-phosphodiesterase extracted from sorghum malt.

Step b is preferably carried out using yeast exogenous enzymes, particularly proteases to increase the degradation of yeast proteins. Examples of such proteases are plant proteases (papain, bromelain, etc.) or microbial proteases (Bacillus subtilis, Aspergillus oryzae, ....).

The method may comprise a step of total or partial purification of the RNA before the step of treatment with 5'-phosphodiesterase of sorghum. In a preferred embodiment, the step of treating the yeast suspension with the 5'-PDE sorghum is preferably carried out at a pH of between 5.0 and 7.5 with a temperature between 35 and 70 ^%. C. The incubation time of the yeast suspension with 5'-PDE sorghum can vary from 5 to 30 hours. Preferably, the 5'-PDE sorghum preparation is added to the yeast suspension at 10% w / w. For example, the step of treating the yeast suspension with 5'-PDE sorghum can be done at 60 ⁰ C for 18 h at a pH of 6.3.

Preferably, the yeast extract is rich in 5'-GMP and / or 5'-IMP. Notably, levels of 5'-GMP and 5'-IMP of 0.1 to 15% each (expressed as di-sodium salt and hepta-hydrate) can be achieved, preferably 2 to 5%. The yeast extract obtained is devoid of gluten.

The method may further include a step of treating the yeast suspension with a deaminase. This treatment can be done during or after treatment of the yeast suspension with the sorghum PDE. In a preferred embodiment, this deaminase treatment step is performed simultaneously or after the sorghum PDE treatment step. For example, deaminase may be added during the last hours of 5'-PDE treatment, after cooling the suspension, for example to 45 ° C. This step allows transform the 5'-AMP into the desired 5'-IMP. This additional step is well known to those skilled in the art and is described, for example, in EP 249,435 and EP 354,610. An example of a commercially available deaminase is the Amano 50060G Deamizyme. In a particular embodiment, the method comprises a fermentation step for converting the polysaccharides into organic acids such as lactic or succinic acid. This step is well known to those skilled in the art and is for example described in EP 191 513 and EP 354 610. This fermentation may be preferably carried out using bacteria of the genus Lactobacillus or equivalent. Preferably, the yeast extract is then separated from the insoluble portion of the yeast cells. The yeast extract thus separated from the insoluble part offers the advantage of better preservation without the appearance of aromatic notes due to the oxidation of the membrane lipids of the insoluble part. For example, this step can be performed by centrifugation or filtration and recovery of the liquid fraction.

The liquid fraction can then undergo all known downstream treatments of yeast extracts, including concentration, filtration, pasteurization and / or drying.

As previously indicated, yeast extracts are commonly used as a flavor enhancer. By "yeast extract" is meant according to the invention, concentrates of the soluble fraction of yeasts, generally obtained by autolysis or hydrolysis.

The yeast extract rich in 5'-nucleotides can be in various forms, such as, for example, in liquid, pasty or solid form. The yeast extract comprises at least 90% by weight of preferred material, preferably 94% to 98% by weight, of solids.

The invention thus relates to the yeast extracts obtained or obtainable by the method according to the present invention and their applications in the food field. These yeast extracts are devoid of gluten. They preferably comprise 5'-GMP and 5'-IMP levels of 0.1 to 15% each (expressed as sodized salt and hepta-hydrated salt).

The present invention relates to the use of yeast extracts according to the the present invention in a food formula, the food formula thus obtained and the consumer food product obtained based on this formula. The food formula can be, for example, a broth formula, a soup, a sauce, a cooked dish, a bakery dough or a condiment. The invention also relates to flavoring agents comprising a yeast extract according to the present invention. The flavoring agent according to the present invention may also comprise insoluble materials.

The invention also relates to the use of a flavoring agent according to the present invention in a food formula, the food formula thus obtained and the consumer food product obtained based on this formula. The food formula can be, for example, a broth formula, a soup, a sauce, a cooked dish, a bakery product or a condiment.

Thus, the invention relates to a method for flavoring food products, characterized in that a flavoring agent according to the present invention is used.

The following examples are provided to illustrate the invention and should in no way be considered as a limit to the scope of the invention.

EXAMPLE 1 Preparation of Sorghum Root Extract

The rootlets used are from an African sorghum malting plant. 13 g of sorghum rootlets are crushed or milled, so as to obtain a powder having a mean size granuloma of 500 μm.

This powder is decocted at 13% (w / w) in an aqueous solution of zinc acetate at 0.2 g / l at a temperature of 60 ^° C. for 2 hours.

The extract of sorghum rootlets is obtained after extraction of the solids and insolubles from the decoction by two centrifugal separation steps. EXAMPLE 2

Preparation of a yeast extract rich in 5'-nucleotides - Comparison between 5'-PDE from sorghum and the commercial enzyme 1000 g of yeast cream of the genus Saccharomyces cerevisiae having a solids content of 15% and a content of 9.5% RNA (measured by hydrolysis according to the Trevelyan method as described in: Induction of Autolytic Breakdown of RNA in Yeast by Addition of Ethanol and by Drying / Rehydration, Trevelyan, J., Sci., Food Agric, 1977, 28, 579-588, and in Processing Yeast to Reduce its Nucleic Acid Content, Induction of Intracellular RNAse Action by a Simple Heat-shock Procedure, and an Efficient Chemical Method Based on Extraction of RNA by Sait Solutions at Low pH; Chem., Ind., 1978, ppl41-174) is heat-treated at 75 ° C for 2 hours, then cooled to 56 ° C and adjusted to a pH of 5.3 (plasmolysis). This cream is mixed with the supernatant of the decoction of sorghum rootlets containing 5'-PDE (10% w / w). The whole is allowed to incubate with slow stirring for 15 h at 56 ^° C., so as to hydrolyze the RNA in 5'-nucleotides. The solids are then separated by centrifugation and washed with demineralized water before being centrifuged again. The two supernatants are pooled, concentrated and spray-dried. The analysis of the powder shows a 5'-GMP content of 2.44% (expressed in the form of sodium salt and heptahydrate). The assay is performed by RP-HPLC, as described in: Enzymatic Production of Ribonucleotides from Autolysates of Kuyveromyces marxianus grown on whey; Belem, MAF, et al., Journal of Food Science, 62, pp. 851-854. 1 kg of the same plasmolysed cream under identical conditions and incubated for 15 hours with 1 g of Amano commercial 5'-PDE (commercial name = PDE RP-I, Amano Enzyme Europe, Ltd) conducted after separation, concentration and drying to a powder grading 2.60% 5'-GMP. The efficiency of hydrolysis is therefore similar in both cases, and 5'-PDE from sorghum is as effective in terms of hydrolysis of RNA as the much more expensive commercial enzyme. EXAMPLE 3

The process is carried out using 13 g of malted sorghum rootlets and 1000 g of yeast cream as described in the preceding examples. However, after 15 h of incubation, the temperature is decreased to 45 ° C and 0.1 g of Amano 5'-adenylic deaminase (trade name = 50000G Deamizyme, Amano Enzyme Europe, Ltd) are added. The whole is incubated for 5 hours to allow the conversion of 5'-AMP to 5'-IMP by 5'-adenylic deaminase. The solids are then separated by centrifugation and washed with demineralized water before being centrifuged again. The two supernatants are pooled, concentrated and spray-dried. The analysis of the powder shows a 5'-GMP content of 2.80% and a content of 5'-IMP of 3.21% (assay by RP-HPLC, both expressed in the form of sodium salt and hepta). -hydrate).

EXAMPLE 4

The process is carried out using 13 g of malted sorghum rootlets and 1000 g of yeast cream as described in the preceding examples. However, before addition of the 5'-PDE of sorghum malt, 0.5 g of papain are added in order to increase the solubilization of the dry matter of the yeast. The rest of the process is identical, including, as in Example 3, the addition of 5'-adenylic deaminase. The analysis of the resulting powder shows a 5'-GMP content of 1.96% and a content of 5'-IMP of 2.07% (RP-HPLC assay, both expressed as the sodium salt and hepta-hydrated).

EXAMPLE 5

The process is carried out as in Examples 1 and 2 except that the yeast cream Saccharomyces cerevisiae is replaced by a cream of Candida used dry matter 13% and titrating 12.5% of RNA. Analysis of the resulting powder shows a 5'-GMP content of 3.75% and a 5'-IMP content of 3.98% (both expressed as sodic and hepta-hydrated salt).

Claims

A process for preparing a yeast extract rich in 5'-nucleotides and devoid of gluten, comprising: a) heating a yeast suspension; b) treating the yeast suspension with a 5'-phosphodiesterase; c) separating the insoluble materials from the suspension; and d) recovering the yeast extract; characterized in that the 5'-phosphodiesterase is extracted from sorghum malt rootlets.

2- Method according to claim 1, characterized in that the 5'-phosphodiesterase extracted from sorghum malt roots is prepared by decoction of a powder of sorghum rootlets suspended in an aqueous solution of zinc acetate ( 0.2 to 5 g / l) at a temperature between 50 and 80 ⁰ C for 30 min to 4 h and by removal of the insoluble fraction.

3- A method according to claim 2, characterized in that the particle size of the powder is between 20 and 2000 microns, preferably between 100 and 200 microns.

4- Process according to any one of claims 1-3, characterized in that the step of treating the yeast suspension with 5-phosphodiesterase sorghum is carried out at a pH between 5.0 and 7.5 with a temperature between 35 and 70 ⁰ C and for 5 to 30 h.

5. Process according to any one of claims 1-4, characterized in that the process further comprises a step of enzymatic digestion of the yeast suspension after the heating step.

6. Process according to any one of claims 1-5, characterized in that the method further comprises a step of total or partial purification of the RNA before the step of treatment with 5'-phosphodiesterase sorghum. 7- Method according to any one of claims 1-6, characterized in that the method further comprises a step of treatment with a deaminase.

8- Process according to any one of claims 1-7, characterized in that the yeast RNA content is between 6 and 15% by dry weight.

9- Method according to any one of claims 1-8, characterized in that the yeast is of the genus Saccharomyces, genus Candida or genus Kluyveromyces.

10-yeast extract rich in nucleotides obtainable by the process according to claims 1-9 and without gluten.

11. A flavoring agent comprising a yeast extract rich in 5'-nucleotides according to claim 10 or obtainable by the method according to any one of claims 1-9.

12- Process for flavoring food products, characterized in that a flavoring agent according to claim 11 is used.

13- Food product comprising a flavoring agent according to claim 11.

14 - Use of a 5'-phosphodiesterase extracted from sorghum malt for the preparation of a composition rich in 5'-nucleotides.